MetaVia (MTVA) Debt Ratio (2017 - 2018)
MetaVia's (MTVA) quarterly Debt Ratio came in at 2.47 in Q4 2018, up 368.02% YoY from 0.53 in Q4 2017, and up 509.58% on a QoQ basis from 0.41 in Q3 2018.
MetaVia (MTVA) Debt Ratio (2017 - 2018) Analysis & Trends
MetaVia (MTVA) has 2 years of Debt Ratio data on file, last reported at 2.47 in Q4 2018.
- Quarterly Debt Ratio rose 368.02% year-over-year to 2.47 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was 2.47 (up 368.02% YoY) and the FY2018 annual result came in at 2.47, up 368.02% from the prior year.
- Debt Ratio rose to 2.47 in Q4 2018, from 0.41 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 2.47 in Q4 2018 to a low of 0.29 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.47 |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 2.47 |
| Sep 30, 2018 | 0.41 |
| Jun 30, 2018 | 0.35 |
| Mar 31, 2018 | 0.29 |
| Dec 31, 2017 | 0.53 |
| Sep 30, 2017 | 0.38 |